106 related articles for article (PubMed ID: 26679816)
21. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
22. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
[TBL] [Abstract][Full Text] [Related]
23. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
24. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
25. In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells.
Hassan EM; Willmore WG; McKay BC; DeRosa MC
Sci Rep; 2017 Nov; 7(1):14487. PubMed ID: 29101327
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of four ultrasonography techniques in predicting histopathological classification of canine mammary carcinomas.
Feliciano MAR; Ramirez RAU; Maronezi MC; Maciel GS; Avante ML; Senhorello ILS; Mucédola T; Gasser B; Carvalho CF; Vicente WRR
Vet Radiol Ultrasound; 2018 Jul; 59(4):444-452. PubMed ID: 29430763
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonography methods for predicting malignancy in canine mammary tumors.
Feliciano MAR; Uscategui RAR; Maronezi MC; Simões APR; Silva P; Gasser B; Pavan L; Carvalho CF; Canola JC; Vicente WRR
PLoS One; 2017; 12(5):e0178143. PubMed ID: 28542533
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
[TBL] [Abstract][Full Text] [Related]
31. Circulating level of heat shock protein 27 is elevated in dogs with mammary tumors.
Birdi R; Kumar BVS; Gupta K; Kashyap N; Kumar A
3 Biotech; 2019 Jun; 9(6):229. PubMed ID: 31139544
[TBL] [Abstract][Full Text] [Related]
32. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.
Bhargava R; Beriwal S; Dabbs DJ
Am J Clin Pathol; 2007 Jan; 127(1):103-13. PubMed ID: 17145637
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
34. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
35. Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features.
Estrela-Lima A; Araújo MS; Soares RP; Ribeiro LG; Damasceno KA; Costa AT; Teixeira-Carvalho A; Martins-Filho OA; Cassali GD
Vet Comp Oncol; 2016 Mar; 14(1):88-100. PubMed ID: 24571435
[TBL] [Abstract][Full Text] [Related]
36. Prognostic status of p53 gene mutation in canine mammary carcinoma.
Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
[TBL] [Abstract][Full Text] [Related]
37. Concerns about mammaglobin assays.
Span PN; Grebenchtchikov NI; Geurts-Moespot A; Sweep FC
Clin Chem; 2005 Feb; 51(2):474-5. PubMed ID: 15681567
[No Abstract] [Full Text] [Related]
38. Mammaglobin a in breast cancer: existence of multiple molecular forms.
O'Brien NA; O'Donovan N; Ryan B; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Int J Cancer; 2005 Apr; 114(4):623-7. PubMed ID: 15609337
[TBL] [Abstract][Full Text] [Related]
39. Identification of mammaglobin B, a novel member of the uteroglobin gene family.
Becker RM; Darrow C; Zimonjic DB; Popescu NC; Watson MA; Fleming TP
Genomics; 1998 Nov; 54(1):70-8. PubMed ID: 9806831
[TBL] [Abstract][Full Text] [Related]
40. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
